Aspira Women's Health (AWH)
(Delayed Data from NSDQ)
$1.01 USD
-0.01 (-0.97%)
Updated Aug 30, 2024 01:23 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Aspira (AWH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$4.25 | $5.50 | $3.00 | 316.67% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Aspira comes to $4.25. The forecasts range from a low of $3.00 to a high of $5.50. The average price target represents an increase of 316.67% from the last closing price of $1.02.
Analyst Price Targets (2 )
Broker Rating
Aspira currently has an average brokerage recommendation (ABR) of 2.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 3.00 a month ago based on two recommendations.
Of the three recommendations deriving the current ABR, one is Strong Buy, representing 33.33% of all recommendations. There was no Strong Buy or Buy recommendation a month ago.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/AWH.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.33 | 2.33 | 3.00 | 3.00 | 3.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/14/2024 | Alliance Global Partners | James Molloy | Not Available | Strong Buy |
8/13/2024 | Cantor Fitzgerald & Co | Ross Osborn | Hold | Hold |
7/11/2024 | William Blair | Andrew F Brackmann | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.33 |
ABR (Last week) | 2.33 |
# of Recs in ABR | 3 |
Average Target Price | $4.25 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 77 of 253 |
Current Quarter EPS Est: | -0.28 |